Kee Song Bio-Technology Holdings Limited reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was TWD 733.89 million compared to TWD 606.36 million a year ago. Net income was TWD 53.85 million compared to TWD 18.83 million a year ago.

Basic earnings per share from continuing operations was TWD 1.46 compared to TWD 0.51 a year ago. Diluted earnings per share from continuing operations was TWD 1.46 compared to TWD 0.51 a year ago.